327 related articles for article (PubMed ID: 28951666)
21. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
Abdel-Latif MM; Abdel-Wahab BA
Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
[TBL] [Abstract][Full Text] [Related]
22. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
[TBL] [Abstract][Full Text] [Related]
23. Knowledge, Attitude, and Barriers Toward ADRs Reporting Among Health-Care Professionals at Tertiary Care Health Settings in Peshawar, Pakistan: A Web Based Study.
Ali I; Ahmad W; Ullah AR; Khan F; Ijaz M; Khan S; Khan TM
Hosp Pharm; 2021 Aug; 56(4):384-391. PubMed ID: 34381279
[No Abstract] [Full Text] [Related]
24. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
25. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
[TBL] [Abstract][Full Text] [Related]
26. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
[TBL] [Abstract][Full Text] [Related]
27. Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting.
Hanafi S; Torkamandi H; Hayatshahi A; Gholami K; Javadi M
Iran J Nurs Midwifery Res; 2012 Jan; 17(1):21-5. PubMed ID: 23492864
[TBL] [Abstract][Full Text] [Related]
28. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
29. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
Sweis D; Wong IC
Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
[TBL] [Abstract][Full Text] [Related]
30. Assessing knowledge, attitude, and practices of health-care providers toward pharmacovigilance and adverse drug reaction reporting at a comprehensive cancer center in Jordan.
Al Rabayah AA; Hanoun EM; Al Rumman RH
Perspect Clin Res; 2019; 10(3):115-120. PubMed ID: 31404206
[TBL] [Abstract][Full Text] [Related]
31. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
32. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
Khardali A
Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
[TBL] [Abstract][Full Text] [Related]
33. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
[TBL] [Abstract][Full Text] [Related]
34. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
35. Knowledge, Attitude and Practice of Hospital Pharmacists in Central China Towards Adverse Drug Reaction Reporting: A Multicenter Cross-Sectional Study.
Hu W; Tao Y; Lu Y; Gao S; Wang X; Li W; Jiang Q; Lin L; Sun F; Cheng H
Front Pharmacol; 2022; 13():823944. PubMed ID: 35392558
[No Abstract] [Full Text] [Related]
36. Health-care Professionals' Knowledge and Perception of Adverse Drug Reaction Reporting and Pharmacovigilance in a Tertiary Care Teaching Hospital of Nepal.
Danekhu K; Shrestha S; Aryal S; Shankar PR
Hosp Pharm; 2021 Jun; 56(3):178-186. PubMed ID: 34024926
[No Abstract] [Full Text] [Related]
37. Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat.
Upadhyaya HB; Vora MB; Nagar JG; Patel PB
J Adv Pharm Technol Res; 2015; 6(1):29-34. PubMed ID: 25709967
[TBL] [Abstract][Full Text] [Related]
38. Knowledge, attitudes and practices of nurses and pharmacists towards adverse drug reaction reporting in the South African private hospital sector.
Bogolubova S; Padayachee N; Schellack N
Health SA; 2018; 23():1064. PubMed ID: 31934371
[TBL] [Abstract][Full Text] [Related]
39. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Suyagh M; Farah D; Abu Farha R
Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
[TBL] [Abstract][Full Text] [Related]
40. Pharmacist's Knowledge and Behaviors Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process in Türkiye.
Albayrak A; Karahalil B
Turk J Pharm Sci; 2022 Dec; 19(6):694-700. PubMed ID: 36544389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
